LENZ Therapeutics Reports Q3 2026 Financial Results, Announces Strategic Reorganization and CEO Succession
LENZ Therapeutics reported its third-quarter 2026 financial results and announced a strategic consumer marketing-focused reorganization alongside the transition of its CEO.